Adalta Ltd
ASX:1AD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adalta Ltd
ASX:1AD
|
AU |
|
Rambler Metals and Mining PLC
LSE:RMM
|
UK |
|
Huapont Life Sciences Co Ltd
SZSE:002004
|
CN |
|
Redrow PLC
LSE:RDW
|
UK |
|
ARS Pharmaceuticals Inc
NASDAQ:SPRY
|
US |
|
A
|
Aileron Therapeutics Inc
NASDAQ:ALRN
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 1AD's stock price target?
Not Available
1AD doesn't have any price targets made by Wall Street professionals.
What is Adalta Ltd's Revenue forecast?
Projected CAGR
47%
For the last 8 years the
compound annual growth rate for
Adalta Ltd's revenue is
-12%.
The projected
CAGR
for the next 4 years is
47%.